...
首页> 外文期刊>Asian Pacific Journal of Cancer Prevention >Fibronectin Regulates the Dynamic Formation of Ovarian Cancer Multicellular Aggregates and the Expression of Integrin Receptors
【24h】

Fibronectin Regulates the Dynamic Formation of Ovarian Cancer Multicellular Aggregates and the Expression of Integrin Receptors

机译:纤连蛋白调节卵巢癌多细胞聚集体的动态形成和整联蛋白受体的表达。

获取原文

摘要

Objective: To investigate the regulatory role of fibronectin (FN) in the formation of multicellular aggregate (MCA)in ovarian cancer SKOV3 and OVCAR-3 cells and integrin expression. Methods: The dynamic formation of MCA inSKOV3 and OVCAR-3 was determined using the liquid overlay technique in the presence or absence of FN, anti-FN,RGD peptide, control RGE. The expression of α3β1, α4β1 and α5β1 integrin in monolayer cells, MCA and FN-treatedMCA were determined by flow cytometry and quantitative RT-PCR. Results: OVCAR-3 and SKOV3 MCA were formedon the 4th and 8th day and peaked on the 6th and 9th day, respectively. Treatment with different concentrations of FN,LN, type IV collagen and control RGE peptide promoted MCA growth, which was mitigated by anti-FN and RGDpeptide. In comparison with monolayer cells, up-regulated α3β1, α4β1 and α5β1 expression were detected in MCAwhile treatment with FN in both cells. Conclusions: OVCAR-3 and SKOV3 cells had varying dynamic formation ofMCA in our experimental system. FN enhanced MCA formation in both cells, which was associated with increasedexpression of 3β1, α4β1 and α5β1 in the MCA. Therefore, FN and these integrins may be new therapeutic targets forintervention of ovarian cancer metastasis.
机译:目的:探讨纤连蛋白(FN)在卵巢癌SKOV3和OVCAR-3细胞中多整合素(MCA)形成以及整联蛋白表达中的调控作用。方法:在存在,不存在FN,抗FN,RGD肽,对照RGE的情况下,使用液体覆盖技术测定SKOV3和OVCAR-3中MCA的动态形成。通过流式细胞术和定量RT-PCR确定α3β1,α4β1和α5β1整联蛋白在单层细胞,MCA和经FN处理的MCA中的表达。结果:OVCAR-3和SKOV3 MCA在第4天和第8天形成,并分别在第6天和第9天达到峰值。用不同浓度的FN,LN,IV型胶原蛋白和对照RGE肽处理可促进MCA生长,而抗FN和RGD肽可减轻MCA的生长。与单层细胞相比,在MCA中同时用FN处理的两个细胞中检测到α3β1,α4β1和α5β1表达上调。结论:在我们的实验系统中,OVCAR-3和SKOV3细胞具有不同的MCA动态形成。 FN增强了两种细胞中MCA的形成,这与MCA中3β1,α4β1和α5β1的表达增加有关。因此,FN和这些整联蛋白可能是干预卵巢癌转移的新治疗靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号